Hospital Airway Resuscitation Trial

RECRUITING

I'm interested ...!!

The Hospital Airway Resuscitation Trial (HART) is a cluster-randomized, pragmatic trial of advanced airway management with a strategy of first choice supraglottic airway vs. first choice endotracheal intubation during in-hospital cardiac arrest.

Conditions:

🦠 Cardiac Arrest 🦠 Respiratory Failure

🗓️ Study Start (Actual) 6 February 2023

🗓️ Primary Completion (Estimated) January 2027

✅ Study Completion (Estimated) February 2027

👥 Enrollment (Estimated) 1060

🔬 Study Type INTERVENTIONAL

📊 Phase NA

Locations:

📍 New York, New York, United States

📋 Eligibility Criteria

Description

Inclusion Criteria:

1. Adult aged \>=18 years
2. Admitted to the hospital for any condition
3. Suffered in-hospital cardiac arrest (loss of pulse and ≥2 minutes of chest compressions)
4. Need for assisted ventilation (defined by initiation of bag-mask-ventilation or other supported ventilation)

Exclusion Criteria:

1. Cardiac arrest in the Operating Room or other area not responded to by critical care/ED (Emergency Department) teams.
2. Cardiac arrest in which an invasive airway (i.e. endotracheal tube, tracheostomy tube) is already in place
3. Patients with Do Not Resuscitate or Do Not Intubate orders

Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)

Sexes Eligible for Study: ALL

Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

First Submitted 22 August 2022
First Submitted that Met QC Criteria 25 August 2022
First Posted 30 August 2022

Study Record Updates

Last Update Submitted that Met QC Criteria 7 November 2023
Last Update Posted 8 November 2023
Last Verified November 2023